Treatment of Deficient Subclass or Anti-polysaccharide Antibody Response
NCT00522821
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
55
Enrollment
INDUSTRY
Sponsor class
Conditions
IgG Deficiency
Infections
Interventions
DRUG:
intravenous immunoglobulins
DRUG:
antibiotics
Sponsor
Prothya Biosolutions